Kris Weinberg
Chief Executive Officer chez TELO GENOMICS CORP.
Fortune : 6 640 $ au 31/03/2024
Profil
Kris Weinberg is currently the Chief Executive Officer at Telo Genomics Corp.
Prior to this, he worked as a Director at Lymphoma Research Foundation and as a Director-Oncology Commercial Markets at Theralink Technologies, Inc. He has a graduate degree from Marist College and an undergraduate degree from Siena College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TELO GENOMICS CORP.
0,11% | 07/03/2023 | 80 000 ( 0,11% ) | 6 640 $ | 31/03/2024 |
Postes actifs de Kris Weinberg
| Sociétés | Poste | Début |
|---|---|---|
| TELO GENOMICS CORP. | Chief Executive Officer | 12/12/2022 |
Anciens postes connus de Kris Weinberg
| Sociétés | Poste | Fin |
|---|---|---|
| Lymphoma Research Foundation | Director/Board Member | - |
| THERALINK TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Formation de Kris Weinberg
| Marist College | Graduate Degree |
| Siena College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| THERALINK TECHNOLOGIES, INC. | Health Technology |
| TELO GENOMICS CORP. | Health Services |
| Entreprise privées | 1 |
|---|---|
| Lymphoma Research Foundation |
